Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-12

Clinical Trial Update: A Study To Learn About the Safety Medicine (Called Mylotarg) In People With Acute Myeloid Leukemia

View source ↗

Summary

Pfizer is conducting a safety-focused clinical trial of Mylotarg (gemtuzumab ozogamicin) in adults with acute myeloid leukemia, and the study is currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mylotarg (gemtuzumab ozogamicin)

Snippet

Sponsor: Pfizer | Conditions: Acute Myeloid Leukemia | Status: RECRUITING